首页>>国际

谷神星一号遥三运载火箭发射成功

2022-08-10 13:32:47 | 来源:龙海新闻网
小字号

  北京时候2022年8月9日12时11分,谷神星一号遥三运载火箭在我国酒泉卫星发射中间成功发射升空,将搭载的泰景一号01/02星和东海一号卫星共3颗卫星顺遂送入预定轨道,发射使命取得美满成功。泰景一号01/02星首要用于供给贸易遥感办事,东海一号卫星首要用于验证细小型偏振光相机多模式遥感探测手艺。   此次使命是谷神星一号运载火箭第3次飞翔。   (总台记者 杨弘杨 喻鹏 王茄欢 郑伟杰) 【编纂:唐炜妮】

(责编:adkin)

分享让更多人看到

微信快餐300元坑
首页>>国际

台胞参访北汽集团 感受北京科技新发展

2022-08-10 13:30:48 | 来源:南康市新闻网
小字号

  中新社北京8月9日电 (刘玥晴)由北京市台资企业协会主办的名企参访勾当9日进行,当日约30名台胞赴北京汽车团体有限公司(以下简称“北汽团体”)参访交换。   本次勾当聚焦高科技财产,旨在为台胞构建交换平台与合作渠道。台胞们参不雅了北汽团体研发基地,并进行了座谈交换,领会北汽团体的汗青、研发系统及最近几年来成长环境等,领略北汽团体在高新手艺、新能源范畴的立异成长成绩。   北京台资企业协会副秘书长施心木暗示,但愿台胞能经由过程参访北汽团体等知名企业,深入感触感染故国年夜陆的成长转变和庞大成绩。   北京金桥鹰石创业投资中间投资总监、台青林宜贤告知中新社记者,他的投资范畴触及汽车行业、新能源、无人驾驶等,参访北汽团体是一次可贵的进修机遇。经由过程参不雅北汽团体汗青展览,他领会到年夜陆工业从起步到成熟再到壮大的成长过程。他认为,此次勾当对台胞熟习北京经济社会成长计划、重点范畴成长环境和人材成长需求有很年夜帮忙。   参不雅交换过程当中,台胞们加深了对年夜陆新能源成长和“双碳”方针的熟悉,认为相干环保理念值得台企鉴戒。很多台商加入勾当后暗示,后续或与北汽团体进行本色性合作,增进两岸财产融会。   此次勾当由北京市台办指点,北京市台办副主任刘先传、北京台资企业协会相干负责人员伴随参访。据介绍,北京台资企业协会此后还将延续展开名企参访系列勾当,增进台生领会年夜陆各范畴企业,帮忙他们确立卒业后的就业标的目的。(完) 【编纂:苏亦瑜】

(责编:adkin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2022
  • #CGT Asia 2022
  • August 9th-10th
  • Shanghai China

Asia Cell & Gene Therapy Innovation Summit 2022

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Cell Therapy, Gene Therapy, Innovative Therapy, Next Generation Oncolytic Virus, End to End Development, CDMO, CRO, Regulation, IND Application, GLP, Clinical Trail Design, Continuous Production Process, GMP, Immunomodulation, Viral Vectors, High-Throughput Screening, Transfection, Combination Therapy, IVD, Digital PCR, CRISPR/CAS9 Gene Editing, Humanized Animal models, mRNA Tumor Vaccines, Nanoantibody, BsAbs, Customization Manufacturing, Tumor Microenvironment, Stem Cell Therapy, Recombinant Protein, Targets

Event Highlights

Cell Therapy Industrialization and Commercialization Module Strategy

TCR-T Therapy Market Prospects and Development Trends

Targets Selection and Direction of TCR-T Therapeutic Products

Development Key Points of Universal CAR-NK Cell Therapy Products

iPSC Personalized Diagnosis and Treatment and Application

Research and Development of mRNA Drug and Delivery Vector Technology

Viral Vector Process and Optimization Plan

Difficulty in the Development of Gene Therapy Drugs for Rare Diseases

Current Status of Circular RNA R&D

Who Should Attend

Biopharmaceutical CompaniesPre-Clinical R&DClinical R & DVaccine/Antibody CompaniesCell Therapy CompaniesGene Therapy CompaniesScientific Research InstitutesBiotechnology CompaniesLaboratory Equipment SuppliersDrug TestingAnalytical ServicesProduction Solution Providers (Upstream, Downstream) Life Science and Analytical EquipmentDiagnostic and Testing EquipmentExternal AuthorizationProtein Drugs CompaniesContract Service Providers (CRO, CMO, CDMO) Import and Export EnterprisesHVAC Facilities and Cleanroom Equipment SuppliersGovernment Representatives/Trading InstitutionsPreparation MachineryPharmaceutical EngineeringLaw and Regulation FirmsDrug Delivery System ManufacturersThird Party Logistics ProvidersAutomation/RobotCold Chain Packaging CompaniesPackaging MachineryIndustrial ParksLaboratory ServicesLaboratory/Biochemical/Analytical InstrumentsFine Chemical ManufacturersEnvironmental ProtectionIntermediate ManufacturersRegulatory ServicesSupply ChainNew Drug R & D CompaniesConsultant Companies


Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Speakers

Dr. Xingwang XIE
Dr. Xingwang XIE

CEO

Corregene

Dr. Guojie YE
Dr. Guojie YE

CSO

EXEGENESIS BIO

Dr. Jinghui DOU
Dr. Jinghui DOU

CSO

TriApex Laboratories Co. LTD

Dr. Wenqiang YU
Dr. Wenqiang YU

Senior PI

Institutes of Biomedical Sciences Fudan University

Yan CHANG
Yan CHANG

President

INNOSTAR - National Shanghai Center for New Drug Safety Evaluation and Research

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President, R&D, Catalog Product

GenScript

Mr. Hongdong YU
Mr. Hongdong YU

Director of Biological Culture Scenario

Haier Biomedical

Xiaochun Wan
Xiaochun Wan

CEO

Shenzhen BinDeBio Ltd.

Kangjian ZHANG
Kangjian ZHANG

Co-Founder, Director and GM

Yuansong Bio

Dr. Andrew LIN
Dr. Andrew LIN

Founder & CEO

Lingyi Biotherapeutics Co. Ltd

Mo MA
Mo MA

CEO

Shenzhen Eureka Biotechnology Co., Limited

Dr. Jinqiao WAN
Dr. Jinqiao WAN

Vice President of R&D Chemistry Center

HitGen Inc.

Chunying Li
Chunying Li

Technical Application Liaison, China

Mission Bio

Hongjiu DAI
Hongjiu DAI

CEO

Nanjing Kaedi Biotherapeutics

Prof. Evelyne Yehudit Bischof
Prof. Evelyne Yehudit Bischof

Professor Doctor

Shanghai University of Medicine and Health Sciences

Yongzhen LIU
Yongzhen LIU

Deputy Director of Center for Drug Safety Evaluation

Shanghai Institute of Materia Medica

Ryan CAWOOD
Ryan CAWOOD

Chief Scientific Officer

WuXi Advanced Therapies

 Lei ZHANG
Lei ZHANG

R&D VP

Neukio Biotherapeutics

Jimin GAO
Jimin GAO

Professor

Wenzhou Medical University

Ke ZHANG
Ke ZHANG

Chief Scientific Officer

SCG Cell

Yun YANG
Yun YANG

CTO

CirCode Bio

Yang WANG
Yang WANG

Director of Research and Development

Wuhan Binhui Biopharmaceutical

Xiaoxi XU
Xiaoxi XU

Director of In Vitro

Crown Bioscience

Mark FANG
Mark FANG

CQO

Shanghai Zhimi Medical Technology

Adam ZHAO
Adam ZHAO

President

AnlongBio

Yunxiang ZHU
Yunxiang ZHU

Vice President

CANbridge Pharma

Frank GAO
Frank GAO

Chief Strategy Officer

BRL Medicine

Tianhong XU
Tianhong XU

CEO

Base Therapeutics

Emily TAN
Emily TAN

Chief Operating Officer

Bennu Biotherapeutics

Fred MAO
Fred MAO

Partner & Managing Director

Frost & Sullivan

Yarong LIU
Yarong LIU

Founder

Grit Biotechnology

Lei SUN
Lei SUN

CTO

GeneMind

John LU
John LU

President & CEO

HebeCell

Yi ZHU
Yi ZHU

Chief Executive Officer

Hillgene

Grace Zhou
Grace Zhou

CEO

ImmVira Pharma

Xiaoqi QI
Xiaoqi QI

Associate Regional Marketing Manager

10x Genomics

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
化学加
人民医生网
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
环球财经
商业观察网
医诺医学
美通社
动脉网
医疗器械创新网
化学网
中国仪器批发网
再生医学
盖德化工网
大健康网
阿仪网
张通社
测序宝
基因君
51健康网
中国健康咨询网
爱爱医
来宝网
露森科研
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings